Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy.
Gregory S AlexanderAriel Eve PollockDanielle AronsMatthew J FerrisJason K MolitorisWilliam F RegineMatthew E WitekPublished in: Journal of clinical imaging science (2023)
Similar to patients treated with photon-based radiation therapy, post-treatment PET/CT has a high NPV for patients with p16+OPC treated with definitive proton therapy and should be used to guide patient management. Additional patients and more events are needed to confirm the PPV of a post-treatment PET/CT in this favorable patient cohort.